← Back to headlines
US Approves First Gene Therapy for Rare Hearing Loss
The United States has approved the first gene therapy designed to treat a rare form of hearing loss. Following this landmark FDA approval, Regeneron plans to offer the therapy for free.
23 Apr, 15:44 — 24 Apr, 04:02
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center2
Center (2)
punch-ngbloomberg
Right1
Right (1)
straits-times
Far R
Geographic diversity— 3 regions13/34
Singapore1Nigeria1US1
Sources
Showing 3 of 3 sources
bloombergHigh109d ago
Regeneron to Offer Hearing-Loss Therapy for Free After FDA Nod - Bloomberg.com
Regeneron to Offer Hearing-Loss Therapy for Free After FDA Nod Bloomberg.com
Read full article →straits-timesMostly Factual109d ago
US approves first gene therapy for rare form of hearing loss - The Straits Times
US approves first gene therapy for rare form of hearing loss The Straits Times
Read full article →punch-ngMostly Factual109d ago
US approves first gene therapy for rare form of hearing loss
The FDA has approved a new gene therapy for hearing loss caused by OTOF gene mutations, a breakthrough treatment offering hope to affected children. Read More: https://punchng.com/us-approves-first-gene-therapy-for-rare-form-of-hearing-loss/
By Punch Newspapers
Read full article →Coverage Timeline
First report: bloomberg · 23 Apr, 15:44|Full coverage: 3 · 12h|Window: 12h
Left-leaningCenterRight-leaning
